Envista Holdings Corp

NYSE:NVST

Estados Unidos / Salud / Equipos y suministros sanitarios

Visión general

Noticias

Finanzas históricas a 5 años

Precio

17,52 USD


Key Metrics	Latest
Total Revenue	2,511 B
Adjusted EBITDA	279,5 M
EBITDA Margin	11,1%
Net Profit Margin	-9,4%
Total Assets	5,351 B
Total Debt	1,548 B

5Y Historical Financial Statements

Summary Financials


Summary Financials

	Fiscal Year Ending					Latest	Year-to-date Ending
(in millions)	Dec-20	Dec-21	Dec-22	Dec-23	Dec-24	12 Months	Dec-23	Dec-24

Revenue	1,929.10	2,508.90	2,569.10	2,566.50	2,510.60	2,510.60	2,566.50	2,510.60
% Growth		0.30	0.02	(0.00)	(0.02)			(0.02)

Adjusted EBITDA	260.20	496.00	497.70	463.00	279.50	279.50	463.00	279.50
% Margin	0.13	0.20	0.19	0.18	0.11	0.11	0.18	0.11

Adjusted EBIT	127.60	372.40	359.90	327.40	156.40	156.40	327.40	156.40
% Margin	0.07	0.15	0.14	0.13	0.06	0.06	0.13	0.06

Adjusted Net Income	95.76	387.56	270.92	135.71	(234.82)	(234.82)	135.71	(234.82)
% Margin	0.05	0.15	0.11	0.05	(0.09)	(0.09)	0.05	(0.09)

Adjusted Basic EPS	0.60	2.40	1.66	0.81	(1.36)	(1.36)	0.81	(1.36)

Cálculos de apoyo

Income Statement

Balance Sheet

Statement of Cashflows


Income Statement
						Original
USD	Fiscal Year Ending					Latest	Year-to-date Ending
(in millions)	Dec-20	Dec-21	Dec-22	Dec-23	Dec-24	Dec-24	Dec-23	Dec-24
	FY - 4	FY - 3	FY - 2	FY - 1	FY	LTM	YTD-1	YTD

Revenue	1,929	2,509	2,569	2,567	2,511	2,511	2,567	2,511
% Growth	NA	30.1%	2.4%	-0.1%	-2.2%			-2.2%

Cost of Revenue	(856)	(1,047)	(1,081)	(1,116)	(1,119)	(1,119)	(1,116)	(1,119)
Gross Profit	1,073	1,462	1,488	1,451	1,392	1,392	1,451	1,392
% Revenue	55.6%	58.3%	57.9%	56.5%	55.4%	55.4%	56.5%	55.4%

Research and Development	(87)	(101)	(100)	(94)	(99)	(99)	(94)	(99)
Selling and Marketing	0	0	0	0	0	0	0	0
General and Admin	(859)	(990)	(1,028)	(1,029)	(1,136)	(1,136)	(1,029)	(1,136)
Other Inc / (Exp)	(85)	(64)	(38)	(319)	(1,195)	(1,195)	(319)	(1,195)
Total Operating Exp	(1,031)	(1,154)	(1,166)	(1,442)	(2,430)	(2,430)	(1,442)	(2,430)

Operating Income	43	309	322	9	(1,038)	(1,038)	9	(1,038)
% Revenue	2.2%	12.3%	12.5%	0.3%	-41.4%	-41.4%	0.3%	-41.4%

Interest Expense	(63)	(54)	(38)	(63)	(46)	(46)	(63)	(46)
Pre-tax Income	(20)	255	284	(55)	(1,085)	(1,085)	(55)	(1,085)
Earnings of Discontinued Ops.	(9)	77	5	0	0	0	0	0
Provision for Taxes	63	9	(46)	(45)	(34)	(34)	(45)	(34)
Net Income to Company	33	341	243	(100)	(1,119)	(1,119)	(100)	(1,119)
% Margin	1.7%	13.6%	9.5%	-3.9%	-44.6%	-44.6%	-3.9%	-44.6%

Minority Interest in Earnings	0	0	0	0	0	0	0	0
Net Income to Stockholders	33	341	243	(100)	(1,119)	(1,119)	(100)	(1,119)

Preferred Dividends	0	0	0	0	0	0	0	0
Other Adj.	9	(77)	(5)	0	0	0	0	0

Net Income to Common	43	264	238	(100)	(1,119)	(1,119)	(100)	(1,119)
% Margin	2.2%	10.5%	9.3%	-3.9%	-44.6%	-44.6%	-3.9%	-44.6%

As Reported
Basic EPS (Continuing Ops)	0.27	1.63	1.46	(0.60)	(6.50)	(6.50)	(0.60)	(6.50)
Diluted EPS (Continuing Ops)	0.26	1.48	1.34	(0.60)	(6.50)	(6.50)	(0.60)	(6.50)

WA Basic Shares Out.	159.60	161.20	162.90	166.90	172.20	172.20	166.90	172.20
WA Diluted Shares Out.	164.10	177.60	177.60	166.90	172.20	172.20	166.90	172.20

EBITDA, EBIT Reconciliation
EBT, Incl. Unusual Items	(20)	255	284	(55)	(1,085)	(1,085)	(55)	(1,085)
Addback: Net Interest Expense	63	54	38	63	46	46	63	46
Addback: Other Non Operating Expenses, Total	1	0	0	0	0	0	0	0
Addback: Depreciation & Amortization	133	124	138	136	123	123	136	123
Addback: Restructuring Charges	84	64	38	35	28	28	35	28
Addback: Merger / Acquisition Expenses	0	0	0	0	0	0	0	0
Addback: Goodwill Impairment	0	0	0	212	961	961	212	961
Addback: Gain (Loss) On Sale Of Invest.	0	0	0	(4)	0	0	(4)	0
Addback: Gain (Loss) On Sale Of Assets	0	0	0	0	0	0	0	0
Addback: Asset Writedown	0	0	0	46	206	206	46	206
Addback: In Process R&D Expenses	0	0	0	0	0	0	0	0
Addback: Insurance Settlements	0	0	0	0	0	0	0	0
Addback: Legal Settlements	0	0	0	0	0	0	0	0
Addback: Other Unusual Items	0	0	0	29	0	0	29	0
Adjusted EBITDA	260	496	498	463	280	280	463	280
% Margin	13.5%	19.8%	19.4%	18.0%	11.1%	11.1%	18.0%	11.1%

Adjusted EBIT	128	372	360	327	156	156	327	156
% Margin	6.6%	14.8%	14.0%	12.8%	6.2%	6.2%	12.8%	6.2%

Adjusted Net Income Reconciliation
Net Income to Company	33	341	243	(100)	(1,119)	(1,119)	(100)	(1,119)
Addback: Unusual Items	84	64	38	319	1,194	1,194	319	1,194
Less: Tax Benefit of Unusual Items (26%)	(22)	(17)	(10)	(83)	(311)	(311)	(83)	(311)
Adjusted Net Income	96	388	271	136	(235)	(235)	136	(235)
% Margin	5.0%	15.4%	10.5%	5.3%	-9.4%	-9.4%	5.3%	-9.4%

Error de carga

Envista Holdings Corp

NYSE:NVST

Estados Unidos / Salud / Equipos y suministros sanitarios

Finanzas históricas a 5 años